Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-16

Clinical Trial Update: Phase II Artesunate Study in Severe Malaria [Phase 2]

View source ↗

Summary

Phase II trial evaluating artesunate for severe malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 2 | Status: COMPLETED